Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-LRRC15, PR-1498487 Vector   (CAT#: GTVCR-WQ2238MR)

This product GTVCR-WQ2238MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting LRRC15. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Chimeric; Humanized
RefSeq NM_001135057.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 131578
UniProt ID Q8TF66
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-LRRC15, PR-1498487 Vector (GTVCR-WQ2238MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1980MR IVTScrip™ pT7-VEE-mRNA-Anti-LAG3, MK-4280 Vector Vector MK-4280
GTVCR-WQ327MR IVTScrip™ pT7-VEE-mRNA-Anti-VEGFA, AGN 150998 Vector Vector AGN 150998
GTVCR-WQ1618MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD3E&TNFRSF17, JNJ-64007957 Vector Vector JNJ-64007957
GTVCR-WQ1974MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL23A, MK-3222 Vector Vector MK-3222
GTVCR-WQ694MR IVTScrip™ pT7-VEE-mRNA-Anti-oxLDL, BI-204 Vector Vector BI-204
GTVCR-WQ1376MR IVTScrip™ pT7-VEE-mRNA-Anti-SLC39A6, hLIV22 Vector Vector hLIV22
GTVCR-WQ525MR IVTScrip™ pSP6-VEE-mRNA-Anti-FASLG, APG-101 Vector Vector APG-101
GTVCR-WQ912MR IVTScrip™ pT7-VEE-mRNA-Anti-CD74, CD74-DOX (ADC) Vector Vector CD74-DOX (ADC)
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.